![Teva Canada Announces the Launch of Teva-Cyclosporine® Ophthalmic Emulsion, the First Generic Version of Restasis® in Canada for the Treatment of Dry Eye Disease Teva Canada Announces the Launch of Teva-Cyclosporine® Ophthalmic Emulsion, the First Generic Version of Restasis® in Canada for the Treatment of Dry Eye Disease](https://mma.prnewswire.com/media/687688/Teva_Canada_Limited_Teva_Canada_Announces_the_Launch_of_Teva_Cyc.jpg?p=twitter)
Teva Canada Announces the Launch of Teva-Cyclosporine® Ophthalmic Emulsion, the First Generic Version of Restasis® in Canada for the Treatment of Dry Eye Disease
![Teva Canada Announces the Launch of Teva-Cyclosporine® Ophthalmic Emulsion, the First Generic Version of Restasis® in Canada for the Treatment of Dry Eye Disease Teva Canada Announces the Launch of Teva-Cyclosporine® Ophthalmic Emulsion, the First Generic Version of Restasis® in Canada for the Treatment of Dry Eye Disease](https://mma.prnewswire.com/media/686979/Teva_Canada_Limited_Teva_Canada_Announces_the_Launch_of_Teva_Cyc.jpg?w=500)
Teva Canada Announces the Launch of Teva-Cyclosporine® Ophthalmic Emulsion, the First Generic Version of Restasis® in Canada for the Treatment of Dry Eye Disease
![Teva's generic of Neoral® Soft Gelatin Capsules: Cyclosporine Capsules, USP MODIFIED (Soft Gelatin Capsules) Teva's generic of Neoral® Soft Gelatin Capsules: Cyclosporine Capsules, USP MODIFIED (Soft Gelatin Capsules)](https://www.tevagenerics.com/globalassets/products/image//C-D/Cycl9019.jpg)